Acumen Pharmaceuticals (ABOS) Prepaid Assets (2020 - 2026)
Acumen Pharmaceuticals recorded quarterly Prepaid Assets of $5.0 million in Q1 2026, down 7.18% quarter-over-quarter from $5.4 million in Q4 2025, and down 13.78% year-over-year from $5.8 million in Q1 2025.
Acumen Pharmaceuticals' Prepaid Assets history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 13.78% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 13.78% YoY), while the FY2025 annual figure was $5.4 million, down 20.18% from the prior year.
- Prepaid Assets came in at $5.0 million for Q1 2026 at Acumen Pharmaceuticals, down from $5.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.7 million in Q4 2024 to a low of $181000.0 in Q3 2023.
- A 5-year average of $3.1 million and a median of $3.3 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 94.64% in 2022 and jumped 1510.55% in 2023, its largest moves.
- Acumen Pharmaceuticals' Prepaid Assets stood at $237000.0 in 2022, then jumped by 1510.55% to $3.8 million in 2023, then jumped by 76.81% to $6.7 million in 2024, then slipped by 20.18% to $5.4 million in 2025, then slipped by 7.18% to $5.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.0 million, $5.4 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 5.94 Mn |
| Jun 30, 2025 | 5.50 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | 457,000.00 |
| Jun 30, 2024 | 405,000.00 |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 237,000.00 |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 4.42 Mn |
| Sep 30, 2021 | 4.84 Mn |
| Jun 30, 2021 | 1.65 Mn |
| Dec 31, 2020 | 543,000.00 |